Skip to main content
. 2012 Oct;33(9):1651–1656. doi: 10.3174/ajnr.A3034

Table 3:

Neurologic outcomes and mortality (ruptured aneurysms)

mRS Frequency (No. of Patients)a Description (No.)
0 8
2 3 Residual deficit after SAH (2), stroke due to stent occlusion after stopping antiplatelet therapy for shunt placement 2 months after procedure (1)
3 1 Symptomatic intracranial hemorrhage following shunt revision while on antiplatelet therapy (1)
6 5 Aneurysm rebleeding (2), complications of SAH/vasospasm (3)
a

One patient lost to follow-up.